Kenneth Skinner

Kenneth Skinner has a diverse work experience in the field of chemistry and biology. Their most recent position is as a Senior Scientist in Chemical Biology at Quantum-Si, starting in March 2022. Prior to that, they worked as a Scientist in Chemistry at 1859 Inc from May 2021 to February 2022. From August 2019 to May 2021, Kenneth was a Postdoctoral Fellow at the University of California, San Diego - School of Medicine. Kenneth also worked as a Scientist in Clinical Chemistry Assay Development at Truvian from July 2018 to May 2019. Kenneth's experience includes a role as a Vertex Fellow in Chemistry at Vertex Pharmaceuticals from September 2017 to September 2018. Kenneth also gained experience as a Scientific Writer Intern at Illumina from June to August 2017. Prior to that, Kenneth pursued a Ph.D. in Chemical Biology at Harvard University from September 2011 to May 2017, during which they held various positions including Teaching Consultant, Resident Tutor, and Teaching Fellow. Kenneth also worked as a Contributor at OZY, an international online magazine, from January to July 2014. Additionally, they served as a GEM Fellow at Oak Ridge National Laboratory in June to August 2012.

Kenneth Skinner's education history includes attending Harvard University in 2014, where they completed a program in Chemical Biology at HBX-Harvard Business School. In the same year, they also pursued a Mini-MBA at Harvard Business School. Prior to their time at Harvard, they studied at Morehouse College from 2007 to 2011, earning a Bachelor of Science (BS) degree in Biology.